Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2

Name: Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2
License: Public Domain

Kafrelsheikh University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143642
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.